Cite
APA Citation
Sticherling, M., Mrowietz, U., Augustin, M., Thaçi, D., Melzer, N., Hentschke, C., Kneidl, J., Sieder, C., & Reich, K. (2017). secukinumab is superior to fumaric acid esters in treating patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial. British journal of dermatology, 177, 1024–1032. http://access.bl.uk/ark:/81055/vdc_100052800745.0x000058